Fresh Day Meds vs yourEra

What we like

• Publishes the full price matrix — one-month, three-month, new-patient and transfer, for both molecules — inside its own subscription terms rather than in marketing copy
• Price lock: your rate does not rise when your prescribed dose increases at renewal
• A genuine no-commitment standard-dose option at $140 semaglutide and $179 tirzepatide for transfers

The caveats

• –The advertised $99 and $140 headline rates are microdose tiers on a three-month prepay — roughly a tenth of a standard dose
• –Plans renew every 23 days rather than monthly, so the effective annual cost is about 9% above the '/mo' figure
• –A $75 non-refundable consultation fee if you miss the physician's callback, and the order is cancelled

What we like

• Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
• Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
• Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted

The caveats

• –Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
• –Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
• –Injectable only — no oral route and no brand-name lane